Reaction

Acute Biphenotypic Leukaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 89 reports · 3 co-occurring drugs

As of the last recalculation, Acute Biphenotypic Leukaemia appears in 89 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 404.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Blinatumomab15404.2404.7
Abiraterone11215.5215.6
Abiraterone Acetate1171.271.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.